This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

OPSUMIT - SERAPHIN and Open-label Extension

Last Updated: 03/20/2024

Summary

A summary of this response is provided as an interactive PDF (iPDF) that can be accessed by clicking the following link:

Graphical user interface

Description automatically generated